ITCI

Intra-Cellular Therapies Inc. - Common Stock

$14.92 +$0.06 +0.40%



Shares Bought8
Shares Sold8
Total16
Shares Owned0
Last Price$14.92
Total Return-$7.25
Range Today$14.83 - $15.21
52 Week Range$7.85 - $22.66
Open$14.83
Market Cap$645.33M
Volume/Average21.57K/675.61K
P/E Ratio-
Dividend/Yield-




Intra-Cellular Therapies, Inc. is a biopharmaceutical company, which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. Its lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. The company also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease, and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. Intra-Cellular Therapies was founded by Paul Greengard on August 29, 2013 and is headquartered in New York, NY.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
10-06-17 14:22 10-18-17 15:09 $16.91 $15.81 -$1.10 -6.50% derarjen crizisaround
10-06-17 14:25 10-18-17 15:13 $16.89 $15.80 -$1.09 -6.45% derarjen crizisaround
08-23-17 13:09 08-23-17 14:50 $14.77 $14.80 +$0.03 +0.20% buyandsell123 stockwizardry
10-06-17 14:24 10-18-17 15:12 $16.88 $15.81 -$1.07 -6.34% derarjen crizisaround
10-10-17 13:32 10-18-17 15:14 $16.50 $15.80 -$0.70 -4.24% crizisaround
10-06-17 14:23 10-18-17 15:11 $16.91 $15.81 -$1.10 -6.51% derarjen crizisaround
10-06-17 14:20 10-18-17 15:08 $16.91 $15.81 -$1.10 -6.50% derarjen crizisaround
10-06-17 14:19 10-18-17 15:07 $16.90 $15.78 -$1.12 -6.62% derarjen